CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) £ in Millions, $ in Millions		6 Months Ended
		Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Operating activities:
Net income before allocation to noncontrolling interest		$ 46.7	$ 79.4
Adjustments to reconcile net income to net cash flows provided by operating activities:
Depreciation and amortization		48.7	38.7
Stock-based compensation expense		6.0	4.9
Deferred income taxes		(12.8)	0.2
Cash used for operating working capital		48.1	58.4
Other		3.2	1.5
Total provided by operating activities		43.7	66.3
Investing activities:
Capital expenditures		(20.1)	(21.4)
Settlement of forward contracts		1.5	0.1
Total used for investing activities		(412.6)	(291.1)
Financing activities:
Dividends paid		(19.5)	(18.3)
Proceeds from stock options exercised		1.3	1.9
Payment of tax withholding on equity awards vested		(5.8)	(6.4)
Debt issuance costs		(0.8)	0.0
Proceeds from revolving credit facility		348.0	280.0
Repayment of revolving credit facility		(342.0)	(65.0)
Repayment of term loan		(36.8)	(2.0)
Total provided by financing activities		344.8	190.2
Effect of exchange rates on cash, cash equivalents and restricted cash		15.2	(9.5)
Decrease in cash, cash equivalents and restricted cash		(8.9)	(44.1)
Cash, cash equivalents and restricted cash at beginning of period1	[1]	173.4	227.2
Cash, cash equivalents and restricted cash at end of period	[2]	164.5	183.1
Current restricted cash		0.9	1.4	$ 0.8	$ 0.0
Noncurrent restricted cash		11.1	6.2	$ 6.8	$ 0.0
Detail of cash used for operating working capital:
Accounts receivable		0.9	1.1
Inventories		(7.9)	(3.1)
Other current assets		(9.9)	(4.5)
Accounts payable		(23.8)	(9.5)
Accrued liabilities		11.9	(25.4)
U.S. and foreign taxes on income		(19.3)	(17.0)
Supplemental disclosure of cash flow information:
Interest paid		25.7	19.2
Income taxes paid		42.2	41.7
Unpaid capital expenditures		2.4	3.5
Amount paid, net of cash acquired		394.0	269.8
Proceeds from term loan		$ 400.4	$ 0.0

[1] Includes both current and non-current balances of restricted cash. Current restricted cash, included within “Other current assets” in our Unaudited Condensed Consolidated Balance Sheets, was $0.8 million and $0.0 million as of December 31, 2024, and 2023, respectively. Non-current restricted cash, included within “Other assets” in our Unaudited Condensed Consolidated Balance Sheets, was $6.8 million and $0.0 million as of December 31, 2024, and 2023, respectively.

[2] Includes both current and non-current balances of restricted cash. Current restricted cash, included within “Other current assets” in our Unaudited Condensed Consolidated Balance Sheets, was $0.9 million and $1.4 million as of June 30, 2025, and 2024, respectively. Non-current restricted cash, included within “Other assets” in our Unaudited Condensed Consolidated Balance Sheets, was $11.1 million and $6.2 million as of June 30, 2025, and 2024, respectively.